Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Healthnostics, Inc.
Healthnostics, Inc. Approves Share Repurchase Program
September 7th, 2008
Healthnostics, Inc. (OTC PK: HNSO), a medical and biotechnology analytics company, announced that its Board of Directors has approved a repurchase program of the company's free-trading shares of common stock. Management is authorized to arrange repurchasing of up to 100,000,000 shares of stock under the plan from time to time until December 31, 2008. Management feels strongly about the company and its growth prospects, and that the repurchase plan at this time is prudent in its stage of development and further enhances shareholder value. The repurchase plan authorizes management, at its discretion, to repurchase the shares in the open market as permitted by securities...
Source: Pharma Investments, Ventures & Law Weekly (2008-09-07)
|
